Navigation Links
VirtualHealth Technologies, Inc. Appoints Former DEA Assistant Administrator to its Advisory Board
Date:12/17/2008

LEXINGTON, Ky., Dec. 17 /PRNewswire-FirstCall/ -- VirtualHealth Technologies, Inc. (OTC Bulletin Board: VHGI) the owners of Veriscrip(TM), the nation's only proven Real-Time Prescription Monitoring System, announced today that it has appointed Anthony Bocchichio to its Advisory Board.

Mr. Bocchichio has over 37 years of experience in Federal drug law enforcement, 25 of which was spent with the Drug Enforcement Agency. He served as both Assistant Special Agent in Charge and Special Agent in Charge in Miami, FL and St. Louis, MO prior to taking the office of Assistant Administrator of the Operational Support Division of the DEA. Throughout his diverse career, Mr. Bocchichio has been responsible for the development and acquisition of new technology in order to better support the operational needs of the DEA. "I am very excited to be a part of such an innovative group of healthcare and technology professionals that make up the VirtualHealth team," says Mr. Bocchichio. "I look forward to sharing my insight into the challenges that face law enforcement in its fight to eliminate drug abuse and diversion."

Jim Renfro, VirtualHealth's President, was quoted as saying, "Anthony is just the right person we need to help provide guidance to our organization as we continue the enhancements to Veriscrip(TM) and in the continuing development of our security applications in Envoii Healthcare." VirtualHealth established its advisory board in an effort to bring in professionals from the various industries it serves that will assist in the successful execution of VirtualHealth's business goals.

This press release contains forward-looking statements that reflect the Company's current expectations regarding future events. While these statements reflect the Company's best current judgment, they are subject to risks and uncertainties. Actual results may differ significantly from projected results due to a number of factors, including, but not limited to assumptions, beliefs and opinions relating to the business and growth strategy of VirtualHealth Technologies, Inc. and its wholly owned subsidiaries Verified Prescription Safeguards, Inc., VPS Holding, LLC, Envoii Healthcare, LLC, Medical Office Software, Inc. and implementation thereof, based upon the Company's interpretation and analysis of financial and market conditions, the decisions of businesses with whom the Company is either engaged in business with or negotiating, healthcare industry trends and management's ability to successfully finance, develop, market, sell and implement its e-commerce and internet solutions, clinical and financial e-transaction services and software applications to physicians, pharmacies, governmental agencies, laboratories, insurance companies, HMOs, and payers. These factors and other risk factors are more fully discussed in the Company's filings with the Securities and Exchange Commission. The Company expressly disclaims any intent or obligation to update any forward-looking statements.

    Contact:  Shareholder Relations
    VirtualHealth Technologies, Inc.
    325 West Main Street, Suite 240
    Lexington, KY 40507
    (859) 455-9255
    Email: Shareholder.Relations@virtualhealthtechnologies.com
    Website: www.virtualhealthtechnologies.com

'/>"/>
SOURCE VirtualHealth Technologies, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. VirtualHealth Technologies, Inc. Announces Management Appointment
2. VirtualHealth Technologies, Inc., Announces Its Associate, Private Access, Appoints Marc Kirshbaum as President & COO
3. VirtualHealth Technologies, Inc., Announces That Its Associate, Private Access, Will Be Partnering with Genetic Alliance To Accelerate Medical Research While Protecting Privacy
4. VirtualHealth Technologies CEO Scott Hare Discusses New Security and Encryption Technologies for Healthcare Sector with CEORoadshow.com in Exclusive Online Audio Interview
5. ReBuilder Medical Technologies, Inc. Reports International Sales Expansion
6. ReBuilder Medical Technologies, Inc. Signs Agreement for Distribution in Maine
7. MedCom USAs Subsidiary Card Activation Technologies, Inc.s SB2 Registration Declared Effective by SEC
8. Neurobiological Technologies, Inc. Announces Receipt of Determination Letter from NASDAQ
9. ReBuilder Medical Technologies, Inc. Increases Staffing by 30% in Three Weeks Due to Increase in Demand for All ReBuilder Medical Products
10. ReBuilder Medical Technologies, Inc. Reports Monthly Sales in 2007 Nearly Doubling Monthly Sales in 2006, Including Record Daily Sales in September 2007
11. ReBuilder Medical Technologies, Inc. Contracts with ETS to Manufacture the Newest Version of its ReBuilder Neuropathy Treatment Device; Expects Sales to Increase 30%
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... ... June 24, 2016 , ... June 19, 2016 is World Sickle ... chronic pain and the benefits of holistic treatments, Serenity Recovery Center of ... Sickle Cell Disease. , Sickle Cell Disease (SCD) is a disorder of the red ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... ... now offering micro-osteoperforation for accelerated orthodontic treatment. Dr. Cheng has extensive experience with ... Damon brackets , AcceleDent, and accelerated osteogenic orthodontics. , Micro-osteoperforation is a ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... the Clinical Decision Making in Emergency Medicine conference in Ponte Vedra Beach, FL. ... articles published in Emergency Medicine Practice and Pediatric Emergency Medicine Practice. ...
(Date:6/24/2016)... ... June 24, 2016 , ... National recruitment firm Slone Partners is ... sequencing and genomics experience, as Vice President of North American Capital Sales at ... for leading the sales team in the commercialization of the HTG EdgeSeq system and ...
(Date:6/24/2016)... ... June 24, 2016 , ... Finally, a bruise cream that ... dermaka cream can be incorporated into the post-surgical treatment plans of a variety of ... , dermaka cream is very effective for bruising and causes a rapid resolution of ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... , June 23, 2016  The National Pharmaceutical ... joined the health policy research organization as its ... , MD, senior vice president and chief scientific ... representative on the NPC Board of Directors. ... that Mallinckrodt has joined us in support of ...
(Date:6/23/2016)... 2016  Delcath Systems, Inc. (NASDAQ: DCTH ... on treatment of primary and metastatic liver cancers, announces ... - www.againsttheodds.eu - has been awarded a ... The website was developed as ... their families who are coping with the devastating diagnosis ...
(Date:6/23/2016)... YORK , June 23, 2016 ... trading session at 4,833.32, down 0.22%; the Dow Jones Industrial ... S&P 500 closed at 2,085.45, down 0.17%. Stock-Callers.com has initiated ... ALKS ), AMAG Pharmaceuticals Inc. (NASDAQ: AMAG ), ... BioTech Inc. (NASDAQ: ADRO ). Learn more about ...
Breaking Medicine Technology: